Does TOFACITINIB Cause Condition aggravated? 16,925 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 16,925 reports of Condition aggravated have been filed in association with TOFACITINIB (XELJANZ XR). This represents 10.9% of all adverse event reports for TOFACITINIB.
16,925
Reports of Condition aggravated with TOFACITINIB
10.9%
of all TOFACITINIB reports
1,441
Deaths
3,639
Hospitalizations
How Dangerous Is Condition aggravated From TOFACITINIB?
Of the 16,925 reports, 1,441 (8.5%) resulted in death, 3,639 (21.5%) required hospitalization, and 1,658 (9.8%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 16,925 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
Rash (8,889)
What Other Drugs Cause Condition aggravated?
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
TOCILIZUMAB (8,471)
Which TOFACITINIB Alternatives Have Lower Condition aggravated Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN